Publications

A Prospective, Multicentre Study to Investigate the Efficacy, Safety and Tolerability of Octreotide Lar (R) (Long-Acting Repeatable Octreotide) in the Primary Therapy of Patients with Acromegaly

AuthID
P-004-9JZ

Author(s)

Mercado, M

Borges, F

Bouterfa, H

Chang, TC

Chervin, A

Farrall, AJ

Patocs, A

Petersenn, S

Podoba, J

Safari, M

Wardlaw, J

Group Author(s)

SMS995B2401 Study Grp

Document Type

Article

Year published

2007

Published

in CLINICAL ENDOCRINOLOGY, ISSN: 0300-0664

Volume: 66, Issue: 6, Pages: 859-868 (10)

Indexing

Wos^®

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1111/j.1365-2265.2007.02825.x

Pubmed: 17465997

Scopus: 2-s2.0-34347380169

Wos: WOS:000246758100016

Source Identifiers

ISSN: 0300-0664

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

A Prospective, Multicentre Study to Investigate the Efficacy, Safety and Tolerability of Octreotide Lar (R) (Long-Acting Repeatable Octreotide) in the Primary Therapy of Patients with Acromegaly

Useful Links

Get Help

Federated Authentication (Click on the image)

A Prospective, Multicentre Study to Investigate the Efficacy, Safety and Tolerability of Octreotide Lar (R) (Long-Acting Repeatable Octreotide) in the Primary Therapy of Patients with Acromegaly

Useful Links

Get Help